Surgical fixation company Via Surgical Ltd disclosed on Monday the receipt of the US Food and Drug Administration 510(k) clearance for the FasTouch Absorbable Fixation System for fixation of prosthetic material to soft tissues in various minimally invasive and open surgical procedures including hernia repairs.

Upon the US FDA approval, the FasTouch Absorbable is commercially available in the USA and will be exclusively distributed in this region by Progressive Medical Inc.

The company added that the FasTouch enables for the first time an automated lockable surgical mesh fixation that is strong and stable yet easily and consistently delivered.

In conjunction, the company's data clearly demonstrates that a lockable solution is more reliable in a dynamic environment and minimises the risk of tack migration or dislodgement that may lead to complications and hernia recurrences. The soft tissue tends to move, shift, contract and its products are designed to lock into the tissue, providing a closed loop, stable and reliable fixation.